| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/08/1995 | WO1995023868A1 Production of fibrinogen in transgenic animals |
| 09/08/1995 | WO1995023867A1 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof |
| 09/08/1995 | WO1995023862A1 Animals with targeted gene disruption |
| 09/08/1995 | WO1995023861A1 HUMAN MEGAKARYOCYTOPOIETIN AND ISOLATION THEREOF, cDNA CLONING, AND PREPARATION OF THE RECOMBINANT PROTEIN |
| 09/08/1995 | WO1995023860A2 KUNITZ DOMAIN INHIBITOR PROTEINS DERIVED FROM ALZHEIMER'S AMYLOID β-PROTEIN PRECURSOR INHIBITOR |
| 09/08/1995 | WO1995023859A2 Novel forms of t cells costimulatory molecules and uses therefor |
| 09/08/1995 | WO1995023858A1 A novel voltage-gated potassium channel gene |
| 09/08/1995 | WO1995023857A1 Yeast strains and modified albumins |
| 09/08/1995 | WO1995023856A1 Chimeric complement inhibitor proteins |
| 09/08/1995 | WO1995023855A2 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells |
| 09/08/1995 | WO1995023814A1 Product and process for t cell regulation |
| 09/08/1995 | WO1995023812A1 Antibiotic stalobacins |
| 09/08/1995 | WO1995023811A1 Novel carbocyclic compounds which inhibit platelet aggregation by interaction with the gpiib/iiia receptor complex |
| 09/08/1995 | WO1995023809A1 Antithrombotic agents |
| 09/08/1995 | WO1995023801A1 Interference suppression agent for use in immuno assaying |
| 09/08/1995 | WO1995023800A1 Photo-activatable biotin derivatives and their use in suppressing interference in immuno assaying |
| 09/08/1995 | WO1995023611A1 Products comprising substrates capable of enzymatic cross-linking |
| 09/08/1995 | WO1995023599A1 Hla-dm is involved in antigen presentation to t lymphocytes |
| 09/08/1995 | WO1995023513A1 Apidaecin-type peptide antibiotics with improved activities and/or different antibacterial spectrum |
| 09/08/1995 | WO1995023512A1 Terminal complement inhibitor fusion genes and proteins |
| 09/08/1995 | WO1995022609A3 Human glutamate receptor proteins |
| 09/08/1995 | WO1995021916A3 Pp32: a newly identified cd45-associated protein |
| 09/08/1995 | WO1995019429A3 Method and reagent for inhibiting hepatitis c virus replication |
| 09/08/1995 | CA2184810A1 Product and process for t cell regulation |
| 09/08/1995 | CA2184580A1 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells |
| 09/08/1995 | CA2184482A1 Determination of cancerous conditions by mage gene expression |
| 09/08/1995 | CA2184356A1 Terminal complement inhibitor fusion genes and proteins |
| 09/08/1995 | CA2184355A1 Chimeric complement inhibitor proteins |
| 09/08/1995 | CA2184277A1 Novel forms of t cells costimulatory molecules and uses therefor |
| 09/08/1995 | CA2184188A1 Antithrombotic agents |
| 09/08/1995 | CA2184113A1 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof |
| 09/08/1995 | CA2184058A1 Kunitz domain inhibitor proteins derived from alzheimer's amyloid .beta.-protein precursor inhibitor |
| 09/08/1995 | CA2183951A1 Antibiotic stalobacins |
| 09/08/1995 | CA2183665A1 Apidaecin-type peptide antibiotics with improved activities and/or different antibacterial spectrum |
| 09/08/1995 | CA2183643A1 Products comprising substrates capable of enzymatic cross-linking |
| 09/08/1995 | CA2161872A1 Hiv immunoassay utilizing recombinant protein and synthetic peptide reagents |
| 09/07/1995 | DE4407423A1 Entstörmittel zum Einsatz bei Immunoassays Suppression equipment for use in immunoassays |
| 09/06/1995 | EP0670494A2 Anti-treponema pallidum antibody immunoassay |
| 09/06/1995 | EP0670369A2 A novel peptide related to human programmed cell death and DNA encoding it |
| 09/06/1995 | EP0670366A1 Proteic extract from Cucumis melo with antioxidant activity and process of preparation, cosmetic or pharmaceutic composition or food composition containing such extract |
| 09/06/1995 | EP0670332A2 Protein complexes having factor VIII:C activity and production thereof |
| 09/06/1995 | EP0670331A1 Process to reactivate purified membrane proteins by freezing |
| 09/06/1995 | EP0670041A1 Fluorescence energy transfer and intramolecular energy transfer in particles using novel compounds |
| 09/06/1995 | EP0669985A1 Conjugate vaccine against group b streptococcus |
| 09/06/1995 | EP0669984A1 Actinobacillus pleuropneumoniae outer membrane lipoprotein a and uses thereof |
| 09/06/1995 | EP0669983A1 Allergenic proteins and peptides from japanese cedar pollen |
| 09/06/1995 | EP0669982A1 Materials comprising and methods of preparation and use for ribosome-inactivating proteins |
| 09/06/1995 | EP0669981A1 Interferon tau compositions and methods of use |
| 09/06/1995 | EP0669980A1 Method of controlling polypeptide production in bacteria |
| 09/06/1995 | EP0669979A1 C-c ckr-1, c-c chemokine receptor |
| 09/06/1995 | EP0669978A1 Flk-1 is a receptor for vascular endothelial growth factor |
| 09/06/1995 | EP0669977A1 Transformed endothelial cells |
| 09/06/1995 | EP0669976A1 Transcription factor dp-1 |
| 09/06/1995 | EP0669973A1 Biological factors and neural stem cells |
| 09/06/1995 | EP0669941A1 Method of reducing multidrug resistance in cells and tissues |
| 09/06/1995 | EP0669940A1 Specifically crosslinked hemoglobin with free functionality |
| 09/06/1995 | EP0669939A1 Somatotropin modifications |
| 09/06/1995 | EP0669938A1 PEPTIDE DERIVATIVES OF $g(a)-MSH AND THEIR APPLICATION |
| 09/06/1995 | EP0669937A1 Peptide inhibitors of fibronectin and related collagen-binding proteins |
| 09/06/1995 | EP0669934A1 Process for manufacturing crystals of growth hormone and crystals thereby obtained |
| 09/06/1995 | EP0669933A1 PURIFICATION OF FUSION PROTEINS COMPRISING GM-CSF and IL-3 |
| 09/06/1995 | EP0669930A1 Cellular genes encoding retinoblastoma-associated proteins |
| 09/06/1995 | EP0669929A1 Novel cytokine designated elk ligand |
| 09/06/1995 | EP0669925A1 Aids therapeutics based on hiv ma peptides |
| 09/06/1995 | EP0669913A1 Detection of hypoxia |
| 09/06/1995 | EP0669833A1 USES OF TGF-$g(b) RECEPTOR FRAGMENT AS A THERAPEUTIC AGENT |
| 09/06/1995 | EP0669829A1 Enhancement of xenograft tolerance and porcine cytokines therefor |
| 09/06/1995 | EP0590059A4 Production and recovery of recombinant neurotrophins |
| 09/06/1995 | EP0548175B1 Transcription initiation regulating nucleotide sequence |
| 09/06/1995 | EP0529075B1 Hybrid calcitonin |
| 09/06/1995 | EP0529010B1 Mammalian cells expressing a hybrid receptor |
| 09/06/1995 | EP0474797B1 Protein having a transactivating property, vectors expressing this protein, cell lines, and uses thereof |
| 09/06/1995 | EP0394386B1 Method for producing native hiv gp160 |
| 09/06/1995 | EP0317627B1 Oncogene-encoded polypeptide having growth factor activity and methods of production and use thereof |
| 09/06/1995 | EP0151579B1 Method and products for detection of human t cell leukemia virus |
| 09/06/1995 | CN1108030A New sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents |
| 09/06/1995 | CN1107891A Human megacaryocyte auxin and its separating purification and gene clone method and application |
| 09/06/1995 | CN1107887A Methods for producing protein C |
| 09/06/1995 | CN1107857A Cyclic amino acid derivativges |
| 09/06/1995 | CN1029684C Process for preparing dynophine derivative |
| 09/05/1995 | US5447959 Vitamin A derivatives |
| 09/05/1995 | US5447914 Bactericides, fungicides |
| 09/05/1995 | US5447913 Therapeutic uses of bactericidal/permeability-increasing protein dimer products |
| 09/05/1995 | US5447911 Antitumor agents |
| 09/05/1995 | US5447870 Affinity separation, immunoassay |
| 09/05/1995 | US5447862 Pectin lyase genes of aspergillus niger |
| 09/05/1995 | US5447860 Tyrosine kinase |
| 09/05/1995 | US5447859 Method for the purification or removal of retroviruses using sulfated cellulose |
| 09/05/1995 | US5447858 Heat resistance, plants |
| 09/05/1995 | US5447852 DNA encoding cyclophilin C, and recombinant methods employing it |
| 09/05/1995 | US5447851 DNA encoding a chimeric polypeptide comprising the extracellular domain of TNF receptor fused to IgG, vectors, and host cells |
| 09/05/1995 | US5447843 Heat shock/stress response proteins and prognosis in cancer |
| 09/05/1995 | US5447840 Receptor of the small rhinovirus receptor group |
| 09/05/1995 | US5447836 Bacterial detection by phage transduction of ice nucleation and other phenotypes |
| 09/05/1995 | CA1336896C Process for extracting and purifying epidermin |
| 09/04/1995 | CA2116924A1 Collagenase activating factor and treatment of mammalian tissue therewith |
| 08/31/1995 | WO1995023234A1 Isolated, tyrosinase derived peptides and uses thereof |
| 08/31/1995 | WO1995023233A1 Method for carbohydrate engineering of glycoproteins |
| 08/31/1995 | WO1995023231A1 Cell lines for the identification of substances affecting insulin receptor mediated signal transduction |
| 08/31/1995 | WO1995023230A1 Promoter from a lipid transfer protein gene |